Nebulised heparin for patients on ventilation : implications for COVID-19 pneumonia
| Errataetall: |
CommentOn: Lancet Respir Med. 2021 Apr;9(4):360-372. - PMID 33493448 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
The Lancet. Respiratory medicine - 9(2021), 4 vom: 30. Apr., Seite 321-322 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ball, Lorenzo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 09.04.2021 Date Revised 28.10.2021 published: Print-Electronic CommentOn: Lancet Respir Med. 2021 Apr;9(4):360-372. - PMID 33493448 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S2213-2600(20)30513-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320554945 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320554945 | ||
| 003 | DE-627 | ||
| 005 | 20231225173830.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2213-2600(20)30513-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320554945 | ||
| 035 | |a (NLM)33493452 | ||
| 035 | |a (PII)S2213-2600(20)30513-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ball, Lorenzo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nebulised heparin for patients on ventilation |b implications for COVID-19 pneumonia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.04.2021 | ||
| 500 | |a Date Revised 28.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Lancet Respir Med. 2021 Apr;9(4):360-372. - PMID 33493448 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Heparin |2 NLM | |
| 650 | 7 | |a 9005-49-6 |2 NLM | |
| 700 | 1 | |a Schultz, Marcus J |e verfasserin |4 aut | |
| 700 | 1 | |a Pelosi, Paolo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Respiratory medicine |d 2013 |g 9(2021), 4 vom: 30. Apr., Seite 321-322 |w (DE-627)NLM232005109 |x 2213-2619 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g number:4 |g day:30 |g month:04 |g pages:321-322 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2213-2600(20)30513-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |e 4 |b 30 |c 04 |h 321-322 | ||